Mirati Therapeutics (NASDAQ:MRTX) Research Coverage Started at StockNews.com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
International Biotechnology Trust PLC grew its position in shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX – Free Report) by 6.6% in the 2nd quarter, Holdings Channel reports. The firm owned 260,000 shares of the biotechnology company’s stock after acquiring an additional 16,000 shares during the quarter. Mirati Therapeutics accounts for about 2.9% of International Biotechnology Trust […]
International Biotechnology Trust PLC Purchases 16,000 Shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX) tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
B. Riley downgraded shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) from a buy rating to a neutral rating in a research note published on Monday morning, Marketbeat Ratings reports. They currently have $60.00 price objective on the biotechnology company’s stock, down from their previous price objective of $65.00. Other research analysts also recently issued […]
StockNews.com assumed coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) in a research report report published on Thursday morning. The firm issued a sell rating on the biotechnology company’s stock. MRTX has been the subject of several other reports. Scotiabank assumed coverage on Mirati Therapeutics in a report on Thursday, July 27th. They […]